Radiotherapy (RT) to the primary tumour for men with newly-diagnosed metastatic prostate cancer (PCa): Survival results from STAMPEDE

被引：0

作者：

Parker, C. C. ^{[1
]}

James, N. D. ^{[2
]}

Brawley, C. ^{[3
]}

Clarke, N. W. ^{[4
,5
]}

Attard, G. ^{[6
,7
]}

Chowdhury, S. ^{[8
]}

Cross, W. ^{[9
]}

Dearnaley, D. P. ^{[10
]}

Gilson, C. E. ^{[3
]}

Jones, R. ^{[11
]}

Mason, M. D. ^{[12
]}

Millman, R. ^{[13
]}

Gillessen, S. ^{[14
,15
,16
]}

Eswar, C. ^{[17
]}

Gale, J. ^{[18
]}

Lester, J. ^{[20
]}

Sheehan, D. ^{[19
]}

Tran, A. ^{[20
]}

Parmar, M. K. ^{[3
]}

Sydes, M. R. ^{[3
]}

机构：

[1] Royal Marsden NHS Fdn Trust, Inst Canc Res, Urol, Sutton, Surrey, England

[2] Queen Elizabeth Univ Hosp Birmingham NHS Fdn Trus, Clin Trials Unit, Birmingham, W Midlands, England

[3] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit, London, England

[4] NGS Fdn Trust, Christie Hosp, Manchester, Lancs, England

[5] NGS Fdn Trust, Salford Royal Hosp, Manchester, Lancs, England

[6] Inst Canc Res, Med Oncol, London, England

[7] Royal Marsden, London, England

[8] Guys & St Thomas Hosp NHS Trust, London, England

[9] LIMM, Dept Urol, Leeds, W Yorkshire, England

[10] Inst Canc Res, London, England

[11] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland

[12] Velindre Hosp, Velindre Canc Ctr, Cardiff, S Glam, Wales

[13] MRC, Clin Trials Unit, London, England

[14] Univ Manchester, Div Canc Sci, Manchester, Lancs, England

[15] Christie, Manchester, Lancs, England

[16] Univ Bern, Kantonsspital St Gallen, Div Med Oncol & Haematol, Bern, Switzerland

[17] Clatterbridge Canc Ctr, Liverpool, Merseyside, England

[18] St Marys Hosp, Portsmouth Oncol Ctr, Portsmouth, Hants, England

[19] Royal Devon & Exeter Hosp, Exeter Oncol Ctr, Exeter, Devon, England

[20] Christie NHS Fdn Trust, Manchester, Lancs, England

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

基金：

英国医学研究理事会;

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA5_PR

引用

页数：2

共 50 条

[1] Radiotherapy (RT) to the primary tumour for men with newly- diagnosed metastatic prostate cancer (PCa): Survival results from STAMPEDE (NCT00268476)
Parker, Christopher C.
James, Nicholas D.
Brawley, Chris
Clarke, Noel W.
Attard, Gerhardt
Chowdhury, Simon
Cross, Bill
Gilson, Clare
Jones, Robert J.
Millman, Robin
Dearnaley, David P.
Mason, Malcolm D.
Ritchie, Alastair
Russell, J. Martin
Ali, Syed Adnan
Eswar, Chinnamani
Gale, Joanna
Hoyle, Alex
Lester, Jason
Sheehan, Denise
Tran, Anna
Gillessen, Silke
Amos, Claire
Parmar, Mahesh K. B.
Sydes, Matthew R.
[J]. BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 37 - 37
[2] Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE)
Kretschmer, Alexander
Gleave, Martin E.
[J]. EUROPEAN UROLOGY, 2019, 75 (04) : 692 - 693
[3] Report from the ESMO 2018 presidential symposium-Radiotherapy to the primary tumour for men with newly diagnosed metastatic prostate cancer: survival results from STAMPEDE
Parker, Chris
[J]. ESMO OPEN, 2018, 3 (06)
[4] Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Parker, Christopher C.
James, Nicholas D.
Brawley, Christopher D.
Clarke, Noel W.
Hoyle, Alex P.
Ali, Adnan
Ritchie, Alastair W. S.
Attard, Gerhardt
Chowdhury, Simon
Cross, William
Dearnaley, David P.
Gillessen, Silke
Gilson, Clare
Jones, Robert J.
Langley, Ruth E.
Malik, Zafar I.
Mason, Malcolm D.
Matheson, David
Millman, Robin
Russell, J. Martin
Thalmann, George N.
Amos, Claire L.
Alonzi, Roberto
Bahl, Amit
Birtle, Alison
Din, Omar
Douis, Hassan
Eswar, Chinnamani
Gale, Joanna
Gannon, Melissa R.
Jonnada, Sai
Khaksar, Sara
Lester, Jason F.
O'Sullivan, Joe M.
Parikh, Omi A.
Pedley, Ian D.
Pudney, Delia M.
Sheehan, Denise J.
Srihari, Narayanan Nair
Tran, Anna T. H.
Parmar, Mahesh K. B.
Sydes, Matthew R.
[J]. LANCET, 2018, 392 (10162): : 2353 - 2366
[5] Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): a Randomised Controlled Phase 3 Trial
Taneja, Samir S.
[J]. JOURNAL OF UROLOGY, 2019, 202 (01): : 32 - 33
[6] Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): A Randomised Controlled Phase 3 Trial
Tilki, Derya
Evans, Christopher P.
[J]. EUROPEAN UROLOGY, 2019, 75 (03) : 535 - 536
[7] Radiotherapy to the Primary Tumour for Patients with Metastatic Prostate Cancer: Practice-Changing Results from STAMPEDE
Malik, Z. I.
Fenwick, J. D.
[J]. CLINICAL ONCOLOGY, 2020, 32 (05) : 327 - 329
[8] Long-term outcomes of prostate radiotherapy for newly-diagnosed metastatic prostate cancer
Scott C. Morgan
Oliver E. Holmes
Julia Craig
Scott Grimes
Shawn Malone
[J]. Prostate Cancer and Prostatic Diseases, 2021, 24 : 1041 - 1047
[9] Long-term outcomes of prostate radiotherapy for newly-diagnosed metastatic prostate cancer
Morgan, Scott C.
Holmes, Oliver E.
Craig, Julia
Grimes, Scott
Malone, Shawn
[J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (04) : 1041 - 1047
[10] Management of newly-diagnosed metastatic prostate cancer
Crawford, ED
Boccon-Gibod, L
Bruchovsky, N
Iversen, P
Kirk, D
Kitamura, T
Klein, E
Mc Kiel, C
Labrie, F
McConnell, JD
Vargas, R
[J]. PROSTATE CANCER, 2000, : 351 - 394

← 1 2 3 4 5 →